Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.
Strand Therapeutics is a developer of a biotechnology platform intended to create gene therapies powered by synthetic biology.The company's offerings include immunotherapies to help cells produce target cancer-killing proteins during immunotherapy, enabling patients to improve their body's immune system to fight cancer.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 28, 2022 | Series A | $45M | 4 | FPV Ventures | — | Detail |
Nov 9, 2021 | Grant | $400K | 1 | National Cancer Institute | — | Detail |
Aug 4, 2021 | Grant | $800K | 1 | National Cancer Institute | — | Detail |
Jun 23, 2021 | Series A | $52M | 5 | — | — | Detail |
Jun 4, 2019 | Seed | $6M | 4 | Playground Global | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Aug 10, 2021
WorkMotion
|
Series A | €20.48M | Compliance | — |
Mar 9, 2021
WorkMotion
|
Angel | €2.20M | Compliance | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
FPV Ventures | Yes | Series A |
National Cancer Institute | Yes | Grant |
Eli Lilly & Company Foundation | — | Series A |
Playground Global | — | Series A |
Potentum partners | — | Series A |
ANRI | — | Series A |
BeiGene | — | Series A |
Camford Capital | — | Series A |
Redmile Group | — | Series A |
Creative Destruction Lab (CDL) | — | Seed |